Twelve novel Italian cases of hypophosphatasia: challenging cases with an extremely variable phenotype

Context Hypophosphatasia (HPP) is an inborn error of bone metabolism affecting the musculoskeletal and nervous systems. It is caused by monoallelic or biallelic pathogenic variants of the ALPL gene, which encodes the tissue non-specific alkaline phosphatase (TNSAP). Given its marked clinical variability ranging from prenatal presentations to symptoms onset in late adulthood, HPP often runs undetected with potential harms for affected individuals. Methods Clinical, molecular, in silico , in vitro , and, when accessible, family studies were carried out on 12 HPP individuals with variable clinical presentations. Variants were classified according to the American College of Medical Genetics and Genomics recommendations. Results Four cases were diagnosed as infantile, one as adult HPP. The other cases were completely asymptomatic (nr 4) or showed symptoms not strictly HPP-related (nr 3) but were all identified incidentally based on the biochemical low ALP value or severe bone fragility phenotype. Twelve “pathogenic o likely pathogenic variants” were identified including 9 missense (1 novel, 8 previously reported), 2 in frame indels and one multiexonic deletion. In vitro characterization of the seven point variants without previously described functional data confirmed a dramatic decreased enzymatic activity of some mutated enzymes. Conclusions Improving the recognition of HPP is essential because its rarity and extreme variable presentation with many asymptomatic cases lead to misdiagnosis or delay. Increased clinical awareness and attention to persistently low ALP levels are crucial to achieve earlier and more accurate diagnosis.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-10-28
DOI
https://doi.org/10.3389/fendo.2026.1966666
Primary Topic
Alkaline Phosphatase Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Twelve novel Italian cases of hypophosphatasia: challenging cases with an extremely variable phenotype

Antonio Petracca, Vito Guarnieri, Bartolomeo Augello, Tommaso Biagini et al.
2 links
Frontiers in Endocrinology
Alkaline Phosphatase Research Studies
article

Twelve novel Italian cases of hypophosphatasia: challenging cases with an extremely variable phenotype

Antonio Petracca, Vito Guarnieri, Bartolomeo Augello, Tommaso Biagini, Gaia Tabacco, Marco Castori, Anda Mihaela Naciu, Giovanni Rossini, Mauro Celli, A. Grieco, Giulia Casamassima, Federica Tamburrino, Alfredo Scillitani, Emanuela Scarano, Andrea Palermo, Flavia Pugliese, Tommaso Mazza, Luciano Colangelo, Francesco Petrizzelli, Silvia Morlino, Francesca Pigliaru, Cristina Eller-Vainicher
article en

Abstract

Context Hypophosphatasia (HPP) is an inborn error of bone metabolism affecting the musculoskeletal and nervous systems. It is caused by monoallelic or biallelic pathogenic variants of the ALPL gene, which encodes the tissue non-specific alkaline phosphatase (TNSAP). Given its marked clinical variability ranging from prenatal presentations to symptoms onset in late adulthood, HPP often runs undetected with potential harms for affected individuals. Methods Clinical, molecular, in silico , in vitro , and, when accessible, family studies were carried out on 12 HPP individuals with variable clinical presentations. Variants were classified according to the American College of Medical Genetics and Genomics recommendations. Results Four cases were diagnosed as infantile, one as adult HPP. The other cases were completely asymptomatic (nr 4) or showed symptoms not strictly HPP-related (nr 3) but were all identified incidentally based on the biochemical low ALP value or severe bone fragility phenotype. Twelve “pathogenic o likely pathogenic variants” were identified including 9 missense (1 novel, 8 previously reported), 2 in frame indels and one multiexonic deletion. In vitro characterization of the seven point variants without previously described functional data confirmed a dramatic decreased enzymatic activity of some mutated enzymes. Conclusions Improving the recognition of HPP is essential because its rarity and extreme variable presentation with many asymptomatic cases lead to misdiagnosis or delay. Increased clinical awareness and attention to persistently low ALP levels are crucial to achieve earlier and more accurate diagnosis.

Frontiers in EndocrinologyVol. 17
Università Campus Bio-Medico (IT), Casa Sollievo della Sofferenza (IT), Policlinico Umberto I (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda USL di Bologna (IT), Azienda Ospedaliero-Universitaria Cagliari (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Sapienza University of Rome (IT)
Ministry of Health
Good health and well-being
Openalex Percentile: Top 11%
Alkaline Phosphatase Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon